One Asset Manager Is Sitting at the Center of the Fastest-Growing Corner of Global Finance
Beyond the weight-loss supercycle, a new class of targeted therapies is driving institutional rotation into mid-cap biotech...
Physical supply deficits are colliding with policy-driven demand – and the equities haven't fully priced either
With a $1.8 trillion floor valuation and a June 12 target listing date, this is the trade...
The AI infrastructure buildout has a bottleneck — and MU owns it.
Eli Lilly's Q1 blowout reset the ceiling — and the options flow is telling a very specific...
The numbers from Q1 2026 are too big to talk around — and the market still hasn't...
NVDA beat hard, guided higher, and still slipped. The market's reaction might be the most important signal...
Everyone is chasing the chip trade. The real bottleneck -- and the real opportunity -- is the...
With oil supply down 12.8 million barrels per day and Brent swinging $44 in a single month,...
